MedicaidCoverageMedium impact
KMAP BULLETIN: Preferred Drug List Update – November 2025
Kansas Medicaid (KanCare)·KS · Rheumatology, Endocrinology, Oncology·Pharmacy
Effective date
Nov 1, 2025
We identified it
Jun 21, 2026
Summary
KMAP (Kansas Medicaid) has updated its Preferred Drug List effective November 1, 2025. Four medications including Omnitrope and Adalimumab-aacf are moving to Non-Preferred status, while Orencia and Yuflyma are moving to Preferred status. This affects prior authorization requirements and patient coverage for these specialty medications.
Action Required
By November 1, 2025: Update prior authorization protocols for affected medications - obtain prior auth for newly Non-Preferred drugs (Omnitrope, Adalimumab-aacf, Hadlima) and update preferred alternatives lists to include Orencia and Yuflyma. Monitor KanCare MCO implementation dates as they may vary from state policy date. Check KMAP Open Claims Resolution Log for MCO-specific reprocessing completion dates.